- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04507633
ROMA (Reminiscence, Reality Orientation, Music and Art ) Therapy, Cognition, Depression and Behavioral Problems in the Population With Dementia
March 18, 2022 updated by: Huang, Hui-Chuan, Taipei Medical University
The Effect of ROMA Therapy on Improving Cognitive Functions, Depressive Symptoms and Behavioral Problems in the Population With Dementia
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in population with dementia.
The hypotheis of this study is that these patients with dementia receiving ROMA therapy featuring reminiscence, reality orientation, music, and art would improve their cognition, depressive symptoms, and behavioral symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in demented population.
A total of 60 patients with mild to moderate dementia will be recruited and randomly assigned to two groups: experimental group and control group.
The experimental group will undergo ROMA therapy with a 60 minute per week for eight weeks.
The control group will receive three times ROMA therapy after completing outcome measurements.
Two groups will receive questionnaire interview at pre-test, post-test, and at 4 weeks after intervention.
The measurements comprises: Short Portable Mental Status Questionnaire(SPMSQ), Cornell Scale for Depression in Dementia(CSDD),and Neuropsychiatric Inventory-Questionnaire(NPI-Q).
By identifying the effectiveness of ROMA therapy, suitable intervention can be suggested for those demented population to improve cognitive function, behavioral and psychological symptoms.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
New Taipei City, Taiwan, 234
- Yonghe Zhongxing Public Seniors Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
63 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Been diagnosed as mild to moderate dementia and CDR score between 0.5~2
- can communicate in Chinese or Taiwanese
- without visual or auditory impairment after equipping assist devices
Exclusion Criteria:
- severe dementia and Clinical Dementia Rating (CDR) score more than 2 points
- functional dependence
- incapable of expressing their feelings
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control group
usual care
|
|
Experimental: ROMA therapy
ROMA therapy combines four elements including reminiscence, reality orientation, music, and art in the intervention.
|
An intervention comprising reminiscence of annual festivals, orientation, and familiar music listening and singing, and animation interaction to improve cognitive functions, depressive symptoms and behaviors problems.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cognitive functions
Time Frame: cognitive functions at baseline
|
Short Portable Mental Status Questionnaire(SPMSQ)
|
cognitive functions at baseline
|
cognitive functions
Time Frame: cognitive functions after the completion of intervention
|
Short Portable Mental Status Questionnaire(SPMSQ)
|
cognitive functions after the completion of intervention
|
cognitive functions
Time Frame: cognitive functions at 4 weeks after the completion of intervention
|
Short Portable Mental Status Questionnaire(SPMSQ)
|
cognitive functions at 4 weeks after the completion of intervention
|
depressive symptoms
Time Frame: depressive symptoms at baseline
|
Cornell Scale for Depression in Dementia(CSDD)
|
depressive symptoms at baseline
|
depressive symptoms
Time Frame: depressive symptoms after the completion of intervention
|
Cornell Scale for Depression in Dementia(CSDD)
|
depressive symptoms after the completion of intervention
|
depressive symptoms
Time Frame: depressive symptoms at 4 weeks after the completion of intervention
|
Cornell Scale for Depression in Dementia(CSDD)
|
depressive symptoms at 4 weeks after the completion of intervention
|
behavioral problems
Time Frame: behavioral problems at baseline
|
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
|
behavioral problems at baseline
|
behavioral problems
Time Frame: behavioral problems after the completion of intervention
|
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
|
behavioral problems after the completion of intervention
|
behavioral problems
Time Frame: behavioral problems at 4 weeks after the completion of intervention
|
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
|
behavioral problems at 4 weeks after the completion of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hui-Chuan Huang, PhD, School of Nursing, Taipei Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 25, 2020
Primary Completion (Actual)
July 30, 2021
Study Completion (Actual)
July 31, 2021
Study Registration Dates
First Submitted
July 25, 2020
First Submitted That Met QC Criteria
August 9, 2020
First Posted (Actual)
August 11, 2020
Study Record Updates
Last Update Posted (Actual)
March 21, 2022
Last Update Submitted That Met QC Criteria
March 18, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N202005108
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden